The latest in radiotherapy technology, this “image-guided radiotherapy” improves the accuracy of treatment and limits exposure to healthy tissues. Since tumours vary in size, location and their proximity to sensitive organs, tomotherapy offers a clear advantage when treating certain cancers and considerably improves the quality of patient care.
“We are very proud to have this new machine,” said Dr. Carolyn Freeman, MUHC Director of Radiation Oncology. “As a university health care centre, we are continuing our mandate by remaining on the cutting edge of technology and forging ahead in the fields of research and education.”
Tomotherapy is a new type of X-ray technology. It combines an intensity-modulated radiotherapy device with a scanner that detects the morphology of internal organs. The device travels around a patient lying down on a treatment table and delivers image-guided radiotherapy. This major technological innovation facilitates treatment through the delivery of intensity-modulated beams in three-dimensional space. “By combining an accelerator—which moves around and along the patient—with a scanner, this method provides continuous treatment no matter where the disease is located and follows the cancer’s progression over time,” stated Dr. Freeman.
Three-dimensional images precisely define tumour contours. These images allow doctors to adjust the size, shape and intensity of the beams in relation to the tumour’s unique characteristics, thus limiting the exposure of healthy tissue to radiation. If required, the scanner can also verify the location of the tumour before each treatment so that the patient’s treatment plan can be modified accordingly. A tumour can indeed move a few millimetres from one session to the next. “The advantage of this new technology for patients is that it improves the quality of care and treatment,” added Dr. Freeman.
About the McGill University Health Centre
The McGill University Health Centre (MUHC) is a comprehensive academic health institution with an international reputation for excellence in clinical programs, research and teaching. The MUHC is a merger of five teaching hospitals affiliated with the Faculty of Medicine at McGill University — the Montreal Children's, Montreal General, Royal Victoria, and Montreal Neurological hospitals, as well as the Montreal Chest Institute. Building on the tradition of medical leadership of the founding hospitals, the goal of the MUHC is to provide patient care based on the most advanced knowledge in the health care field, and to contribute to the development of new knowledge.
Seeta Ramdass | McGill University Health Centre
3-D visualization of the pancreas -- new tool in diabetes research
15.03.2017 | Umea University
New PET radiotracer identifies inflammation in life-threatening atherosclerosis
02.03.2017 | Society of Nuclear Medicine
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
27.03.2017 | Health and Medicine
27.03.2017 | Life Sciences
27.03.2017 | Earth Sciences